CClinicalTrials.gg
CompletedNCT06025565Updated Jul 2, 2025

Measuring Pain Experience in Individuals With Lateral Elbow Tendinopathy

An observational study in Elbow Tendinopathy, Tendinopathy and Tennis Elbow, sponsored by Thomas Jefferson University. Completed at 16 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-07-02.

Sponsored by Thomas Jefferson University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The study will address the gaps in the pain experience measurement in those with lateral elbow tendinopathy (LET) by building on the current body of literature, as well as applying modern pain science measures. The comprehensive measurement of various biomedical, psychological, and psychosocial constructs will provide pain profiles that will allow for the subclassification of LET to better inform loading prescriptions based on the systemic effects from LET.

Read the detailed description

Methods: Subjects complete the eight patient reported questionnaires as well as go through 4 clinical examination procedures. Through this cross-sectional design and single session of testing, the investigator seeks to identify associations amongst constructs and variables in order to sub classify patients with LET based on their pain experience.

Study aim 1: The goal of this study is to determine the associations among the various measurements of the pain experience, psychological, psychosocial, and biomedical domains in those with LET.

Research Questions

  1. How is the pain experience in individuals with LET associated with chance locus of control (LOC)?
  2. What is the impact of fear avoidance on the pain experience in those with LET?
  3. How does central sensitization alter the pain experience in those with LET?
  4. Which pain experience measures are associated with functional ability in LET?

Hypotheses

  1. Individuals with chance locus of control (LOC) will exhibit an increase in pain experience measures.
  2. Individuals with fear avoidance will have an increase in pain experience measures.
  3. Individuals with central sensitization (central sensitization inventory (CSI) > 40) will have an increase in pain experience measures.
  4. Pain-free grip strength will have the largest positive correlation with patient-specific functional scale.

Background and Significance

Lateral elbow tendinopathy (LET) is a condition characterized by pain limiting upper extremity function that is not always easily managed, underscoring limits in the understanding and application of pain science. The problems with conservative management of LET appear to be rooted in the understudied and underutilized measurement of pain experience. This lack of research in the application of pain science in those with LET presents an opportunity when determining the appropriate loading of an injured tendon based on different subclassifications.

The complexity of tendinopathy pathogenesis and individual factors influencing the pain experience in those with LET requires a comprehensive series of measures to investigate what is unknown in this area. The use of novel or minimally investigated pain classification and psychological measures will provide insight into their influence on the pain experience to assist with subclassification. Quantitative sensory test (QST) gold standard tests (PPT and PFGS), as well as emerging tests (TPD and laterality), will provide clinical tests that may impact the pain experience and further support the current systematic theoretical mechanisms of tendinopathy. Using a cross-sectional study design will allow for higher recruitment numbers and improve the feasibility of the study. The investigator will investigate the known challenges in the pain measurement of LET and explore how they contribute to the lack of optimal loading in those with LET with respect to the biomedical, psychological, and psychosocial domains.

Subjects will be recruited from clinics in the Philadelphia, PA region. Convenience sampling will be employed through clinical staff to identify eligible subjects using the inclusion and exclusion criteria below. Recruitment will be through flyers and the Office of Recruitment Enhancement services at Thomas Jefferson University utilizing electronic medical record system notifications and emails. Subjects will be screened for eligibility and, if willing to participate, be provided informed consent by the investigator before participation.

Subjects will provide demographic information, and all patient-reported outcome measures (Patient-Specific Functional Scale (PSFS), Numeric Pain Rating Scale (NPRS), Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2), Central Sensitization Inventory (CSI), Multidimensional Health Locus of Control-C (MHLOC), Pain Catastrophizing Scale (PCS), Fear Avoidance Belief Questionnaire (FABQ), and Hospital Anxiety and Depression Scale (HADS). Subjects will then be tested on the physical measures (Two-Point Discrimination (TPD), Pressure Pain Threshold (PPT), Pain-Free Grip Strength (PFGS), and Laterality).

02

Conditions studied

  • Elbow Tendinopathy
  • Tendinopathy
  • Tennis Elbow

Keywords

  • Pain
03

In context

Elbow Tendinopathy

27 studies on the registry are indexed under Elbow Tendinopathy; 10 are open to participants now.

Browse Elbow Tendinopathy studies →

Lead sponsor

Thomas Jefferson University is the lead sponsor of 384 studies on the registry; 71 are open to participants now.

Of its 44 completed or terminated interventional studies of FDA-regulated products, 20 (45%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Outpatient orthopedic clinics and those located throughout the Philadelphia region.

Inclusion criteria

  • English speaking and reading
  • Aged 18-75
  • Diagnosis of lateral elbow tendinopathy provoked by 2 clinical tests: painful resisted 2nd or 3rd finger extension, painful wrist extension, painful stretching of forearm extensor muscles, or painful gripping.

Exclusion criteria

Exclusion Criteria:

  • Receiving any medical intervention for LET from a physician within 90 days. Medical intervention operationally defined as any intervention requiring a medical state license to administer (injection or surgery) or prescribe (medication applied to or ingested that is not available without a physician script) with the exception of patient education.
  • Positive mechanical sensitivity of the median nerve (Upper Limb Tension Test a (ULTTa)).
  • Positive pain provocation of passive elbow flexion.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
70 participants (actual)
Patient registry
No

Groups and cohorts

  • LET

    Patients with tennis elbow.

    Diagnostic Test: Pain Experience Measures

Interventions

  • Diagnostic testPain Experience Measures

    Patient reported outcomes measures, quantitative sensory testing, and physical examination measures.

06

What researchers measure

Primary outcomes

  1. Short Form-McGill Pain Questionnaire-2

    1. The subject will be asked to rate their pain on a 0-10 scale for 22 different pain descriptors. 2. Continuous (1, 5, 6, 8, 9, 10), Intermittent (2, 3, 4, 11, 16, 18), Neuropathic (7, 17, 19, 20, 21, 22), and Affective (12, 13, 14, 15) subscales will be calculated by taking the mean of these items scores in addition to total score. 3. The subject will also mark their pain on a numeric pain rating score. 4. Scale is 0-10. 5. Higher score is worse.

    Time frame: Baseline

  2. Patient Specific Functional Scale

    1. The subject will identify 3 activities that are most limited and meaningful to them. 2. The subject will rate these activities on an 11-point scale ranging from 0 "unable to perform" to 10 "Able to perform the activity at the same level as before the injury or problem." 3. Scale is 0-30. 4. Higher score is better.

    Time frame: Baseline

  3. Central Sensitization Inventory

    1. The subject will be asked to assess for the presence of a central sensitization state on 25 questions scored in ordinal fashion 0 (never) - 4 (always). 2. Data from this instrument will be obtained by recording the total score on a scale of 0-100. 3. Higher score is worse.

    Time frame: Baseline

  4. Multidimensional health locus of control scale form C

    1. The subject rates their opinion or sense that his/her outcomes are determined by luck, fate, or a random occurrence that controls experiences. 2. The 6-point Likert scale is rated from strongly agree to strongly disagree, with 18 questions with 3 subscales including different types of loci of control (LOC; internal, chance, and doctors). 3. Chance LOC scores range from 6-36 in an ordinal measurement. 4. Data from this instrument will be obtained by recording the total score on a scale of 6-36. 5. Higher score is worse.

    Time frame: Baseline

  5. Pain Catastrophizing Scale

    1. The subject will be asked to assess for the presence of a pain catastrophizing on 13 questions scored in ordinal fashion 0 (not at all) - 4 (all the time). 2. Data from this instrument will be obtained by recording the total score on a scale of 0-52. 3. Higher score is worse.

    Time frame: Baseline

  6. Fear Avoidance Belief Questionnaire

    1. The subject will be asked to assess for the presence of fear avoidance behavior. 2. Items are scored on a 6-point Likert scale with questions 2-5 a subscale for work and 6, 7, 9, 10, 11, 12, and 15 for physical activity. 3. Scale is 0-66. 4. Higher score is worse.

    Time frame: Baseline

  7. Hospital Anxiety and Depression Scale

    1. The subject will be asked to assess for the presence of anxiety or depression on 14 questions scored in 4-point Likert scale. 2. Data from this instrument will be obtained by recording the total score and subscores for anxiety and depression. 3. Scale is 0-56 4. Higher score is worse.

    Time frame: Baseline

Secondary outcomes

  1. Pressure Pain Threshold

    1. The subject will be seated with their affected arm positioned in a comfortable, relaxed position on the armrest of a chair. 2. The Commander Echo Algometer will be used to assess the amount of pressure that can be applied at the lateral epicondyle before the onset of pain. The applicator (1 cm) will be positioned over the insertion of the forearm musculature at the lateral epicondyle. 3. The subject will be instructed to verbally indicate when the pain begins by saying "stop." 4. The tester will gradually apply an increasing amount of force at 1kg/second until the subject says "stop." This measure will be taken 3x in an alternating manner, in both arms, starting with the left with a 15 second rest between tests.

    Time frame: Baseline

  2. Two Point Discrimination

    1. Affected elbow will be tested with two point discrimination. 2. Subject will be seated in a neutral position with the elbow resting on the arm of a chair. 3. Subjects will be asked to close their eyes to avoid additional stimulus and input. 4. Calipers will be applied with pressure sufficient to blanch skin along the extensor mass of the elbow. 5. The subject will report after each application "one", if one point is felt or "two", if two points are felt. 6. If unsure, the subject is to report one point. 7. Assessment will begin at 20 mm. The distance between the two points will gradually increase by 1 mm until the subject discerns two points. 8. The distance that the subject first reports two points will be recorded. 9. Measures will be take in both elbows.

    Time frame: Baseline

  3. Laterality

    1. Subject will be seated and given a handheld device to hold. 2. The subject will be instructed to review the images on the screen and as quickly and as accurately as they can, select whether the upper extremity on the screen is either left or right. 3. The subject will complete the test after 25 images and the speed (seconds) and accuracy (%) of the test will be reported.

    Time frame: Baseline

  4. Pain-Free Grip Strength

    1. In a seated position with the affected elbow flexed to 90º and wrist in a neutral position, the subject squeezes the Commander Echo Wireless Grip Strength tester as hard as they can until their elbow pain is reproduced. 2. This procedure will be conducted at each rung position until the grip reproduces the subject's pain. Once the point of a painful grip is reached, the subject can rest for 30 seconds before testing. 3. Subjects will be taken through painful grip testing 3x in each hand in an alternating manner with 15 second breaks between attempts starting in the left hand. 4. Each painful grip measure of kg will be recorded

    Time frame: Baseline

07

Study locations

16 sites
  • Philadelphia Hand to Shoulder Clinic
    Cape May, New Jersey 08210, United States
  • Philadelphia Hand to Shoulder Center
    Cherry Hill, New Jersey 08003, United States
  • Philadelphia Hand to Shoulder Center
    Collegeville, Pennsylvania 19426, United States
  • Jefferson Rehabilitation
    Fairless Hills, Pennsylvania 19030, United States
  • Philadelphia Hand to Shoulder Center
    Glen Mills, Pennsylvania 19342, United States
  • Philadelphia Hand to Shoulder Center
    King of Prussia, Pennsylvania 19406, United States
  • Philadelphia Hand to Shoulder Center
    Langhorne, Pennsylvania 19047, United States
  • Philadelphia Hand to Shoulder Center
    Lansdale, Pennsylvania 19446, United States
  • Thomas Jefferson University
    Philadelphia, Pennsylvania 19107-5084, United States
  • Philadelphia Hand to Shoulder Clinic
    Philadelphia, Pennsylvania 19112, United States
  • Jefferson Rehabilitation
    Philadelphia, Pennsylvania 19130, United States
  • Philadelphia Hand to Shoulder Center
    Rockledge, Pennsylvania 19046, United States
  • Jefferson Rehabilitation
    Torresdale, Pennsylvania 19114, United States
  • Jefferson Rehabilitation
    Warminster, Pennsylvania 18974, United States
  • Jefferson Rehabilitation
    Willow Grove, Pennsylvania 19090, United States
  • Philadelphia Hand to Shoulder Center
    Willow Grove, Pennsylvania 19090, United States
08

References and documents

Study documents

  • Informed consent form · Aug 16, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — Pending discussion with TJU console.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06025565
Lead sponsor
Thomas Jefferson University
Responsible party
Sponsor
First posted
Sep 6, 2023
Start date
Aug 18, 2023
Primary completion
Jun 14, 2025
Completion
Jun 14, 2025
Last update
Jul 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion